Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Proteomics

  • Home
  •  
  • Proteomics



  • Most Read
  • Latest Comments
  • Proteomics signs deal with Omics Global Solutions to provide Chile with early diabetic kidney disease detection
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Proteomics signs deal with Omics Global Solutions to provide Chile with early diabetic kidney disease detection
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Proteomics signs deal with Omics Global Solutions to provide Chile with early diabetic kidney disease detection
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Proteomics signs deal with Omics Global Solutions to provide Chile with early diabetic kidney disease detection
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Proteomics signs deal with Omics Global Solutions to provide Chile with early diabetic kidney disease detection
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

  • TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    • News

  • Proteomics signs deal with Omics Global Solutions to provide Chile with early diabetic kidney disease detection
    • News

    Proteomics signs deal with Omics Global Solutions to provide Chile with early diabetic kidney disease detection

    In Chile, one in eight adults have diabetes. The number of people with the condition there has risen almost 50% in the past ten years. By 2030, the healthcare spending on diabetes in Chile is set to surpass $4 billion. Chile’s healthcare needs demand companies like medical tech company Proteomics (ASX: PIQ) that emphasise early

    Read More
    Public
  • Proteomics’ early detection test for endometriosis potentially a game changer
    • News

    Proteomics’ early detection test for endometriosis potentially a game changer

    Endometriosis is a chronic disease where tissue similar to the lining of the uterus grows outside the uterus. Women are susceptible to this disease over a significant portion of their lives, starting with their first menstrual period, extending through until menopause. For all the advances in medical science, the disease has no known cure. Even

    Read More
    Public
  • Landmark moment for Proteomics’s PromarkerD as it gets published in the UK’s NICE advice
    • News

    Landmark moment for Proteomics’s PromarkerD as it gets published in the UK’s NICE advice

    In the mood for some NICE advice? Here goes: The UK’s National Institute for Health and Care Excellence (NICE) has published a MedTech Innovation Briefing on PromarkerD, i.e. a predictive blood test determining diabetes kidney disease (DKD). The Briefing, dubbed NICE advice, reports that PromarkerD is effective at predicting renal function decline in people with

    Read More
    Public
  • Predictive test for diabetic kidney disease receives new patent
    • News

    Predictive test for diabetic kidney disease receives new patent

    12% of global health expenditure is spent on diabetes. That equates to approximately USD $673 billion. Scarily, 1 in 2 adults with diabetes is undiagnosed.  Diabetic kidney disease (DKD) is directly caused by diabetes, and the damage the disease does to the kidneys. It is estimated that 1 in 3 diabetics will go on to

    Read More
    Public
  • Study results emerge for Proteomics International Laboratories’ latest cancer diagnostic test
    • News

    Study results emerge for Proteomics International Laboratories’ latest cancer diagnostic test

    Your Friday crash course: Diagnostic biomarkers are in essence, used to determine whether or not a patient has a medical condition. Biomarkers can be molecular, histologic, radiographic and physiological, examples include heart rate, BMI and x-ray findings. Proteomics International Laboratories (ASX: PIQ) is taking molecular biomarkers to a whole new level, utilising proprietary biomarkers to

    Read More
    Public
  • Proteomics International to collaborate on world first blood test for endometriosis
    • News

    Proteomics International to collaborate on world first blood test for endometriosis

    One in nine Australian women will suffer from endometriosis, a debilitating, chronic menstrual health disorder resulting in serious pain, fertility issues and reduced quality of life. The disease occurs when tissue similar to that within the lining of the uterus grows outside of the uterus in other areas of the body, commonly around the reproductive

    Read More
    Public
  • 1
  • 2

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.